IDX High Shareholding Concentration (HSC) List Grows to 51 Stocks

Indonesia Stock Exchange (IDX) expanded its High Shareholding Concentration (HSC) list to 51 stocks, adding names including DCII, BYAN, and MORA. The HSC label highlights concentrated ownership and potential liquidity and price sensitivity risks. IDX cited updated methodology and noted regulators are assessing liquidity quality ahead of MSCI review in Nov 2026.

Original reporting
Published Jul 16, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 1:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefRegulation
Primary signal
$SILO
Bearish
low confidence
Mentioned
$SILO · $LUCY
Relevance
6/10
alphai data visualization · based on indonesia-investments.com
Decision brief

The 30-second read

$SILOBearishMed
01

Why it matters

The article argues HSC status can increase perceived liquidity risk, price sensitivity, and foreign investor caution, while also potentially affecting benchmark index weighting. It also notes LUCY’s removal after a controlling shareholder reduced its stake to 34.42%.

02

Market read

Traders may need to adjust short-term liquidity and foreign-flow expectations for newly added HSC stocks, while LUCY’s removal could reduce a liquidity-risk discount.

03

What to watch

Actual investability depends on tradable float, market depth, and execution costs; without evidence of immediate index rebalancing or forced selling, the effect may be more sentiment-driven than structural.

Relevance 6/10Novelty 6/10Timing: today’s publication of IDX’s expanded HSC list and LUCY’s removal update

Background

IDX’s HSC (High Shareholding Concentration) methodology is being expanded, with regulators now evaluating liquidity quality and price discovery efficiency, not only ownership transparency.

Company-level read

Ticker impact

$SILOBearishLow confidence
Context

SILO is newly designated on the HSC list at 96.70% concentration, which the article says can heighten volatility and exit/entry friction.

Expected impact

Possible short-term volatility increase and relative weakness versus non-HSC names.

Evidence & confidence

No additional SILO-specific facts are included beyond the HSC designation and concentration percentage.

$LUCYBullishMedium confidence
Context

LUCY was removed from HSC after a controlling shareholder divestment reduced its stake to 34.42%, implying improved free-float/liquidity optics.

Expected impact

Potential near-term positive drift versus other HSC stocks, assuming investors treat removal as a liquidity-quality upgrade.

Evidence & confidence

Unlike the additions, the article provides a concrete ownership change and a specific new stake level, which is directly tied to the HSC framework.

Market effects

Broadens Indonesia’s focus from ownership transparency to liquidity quality, which can reset how investors screen Indonesian equities for free-float and price-discovery risk.

Could affect foreign allocation behavior across Indonesian listed equities ahead of MSCI/S&P Dow Jones free-float and trading-integrity reviews.

Index-provider scrutiny (MSCI, S&P Dow Jones) and free-float methodology concerns can influence global benchmark inclusion expectations for Indonesian large caps.

Counterpoint

HSC is a classification label, not a fundamental change; price impact may be limited if liquidity is already adequate and investors treat it as informational rather than tradable risk.

Key entities

  • IDX High Shareholding Concentration (HSC) list

    Updated IDX classification that flags stocks with very high ownership concentration, linked to liquidity and price-discovery concerns.

  • MSCI and S&P Dow Jones

    Global index providers cited as raising concerns about free float, ownership transparency, and trading integrity.

  • Lima Dua Lima Tiga (LUCY)

    Removed from HSC after controlling shareholder divestment reduced stake to 34.42%.

Related articles

$SILOMed

Silo Pharma Sinks on Stock Sale

Silo Pharma (NASDAQ: SILO) said it entered definitive agreements for a private placement at-the-market under NASDAQ rules to issue and sell 619,965 shares, or pre-funded warrants, plus Series A-3 and short-term Series A-4 warrants. Price was $6.452 per share, with $6.21 exercise price. Gross proceeds are about $4 million, up to $7.7 million if warrants are fully exercised.

$SILOMedAI 8/10

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Silo Pharma (Nasdaq: SILO) announced a private placement under Nasdaq at-the-market rules to issue 619,965 shares (or pre-funded warrants) at $6.452 per share, with Series A-3 and short-term Series A-4 warrants exercisable immediately. Gross proceeds are expected at about $4.0M, with up to about $7.7M more if warrants are fully exercised. Proceeds will fund working capital and general corporate purposes.

$SILOMedAI 8/10

Silo Pharma, Inc.: Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Silo Pharma (Nasdaq: SILO) announced a private placement priced at-the-market under Nasdaq rules for 619,965 shares (or pre-funded warrants) plus Series A-3 and short-term Series A-4 warrants to buy up to 619,965 shares each. Price is $6.452 per share, with $6.21 warrant exercise. Gross proceeds are about $4M upfront, up to $7.7M if warrants are fully exercised in cash. Net proceeds for working capital and general corporate purposes.

$METAHighAI 8/10

CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall By Investing.com

U.S. stock index futures were mixed premarket on Friday, with S&P 500 futures flat and Nasdaq 100 futures down 0.3% by 08:25 ET. CCC Intelligent Solutions rose 14.5% on a Reuters report it is exploring a sale with Morgan Stanley. Circle gained 7% after OCC approval for a digital currency bank. Meta rose 3.8% on a new AI model. Fermi America fell 14.6% after pricing $375m convertible notes, and Silo Pharma dropped 22% on an up to $11.7m ATM placement.